3et3
From Proteopedia
| Line 1: | Line 1: | ||
| - | + | {{Seed}} | |
| + | [[Image:3et3.jpg|left|200px]] | ||
| - | The | + | <!-- |
| + | The line below this paragraph, containing "STRUCTURE_3et3", creates the "Structure Box" on the page. | ||
| + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
| + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
| + | or leave the SCENE parameter empty for the default display. | ||
| + | --> | ||
| + | {{STRUCTURE_3et3| PDB=3et3 | SCENE= }} | ||
| - | + | ===Structure of PPARgamma with 3-[5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yl]-propionic acid=== | |
| - | Description: Structure of PPARgamma with 3-[5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yl]-propionic acid | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed | + | <!-- |
| + | The line below this paragraph, {{ABSTRACT_PUBMED_19116277}}, adds the Publication Abstract to the page | ||
| + | (as it appears on PubMed at http://www.pubmed.gov), where 19116277 is the PubMed ID number. | ||
| + | --> | ||
| + | {{ABSTRACT_PUBMED_19116277}} | ||
| + | |||
| + | ==About this Structure== | ||
| + | 3ET3 is a 2 chains structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3ET3 OCA]. | ||
| + | |||
| + | ==Reference== | ||
| + | <ref group="xtra">PMID:19116277</ref><references group="xtra"/> | ||
| + | [[Category: Histone acetyltransferase]] | ||
| + | [[Category: Homo sapiens]] | ||
| + | [[Category: Wang, W.]] | ||
| + | [[Category: Zhang, K Y.J.]] | ||
| + | [[Category: Activator]] | ||
| + | [[Category: Acyltransferase]] | ||
| + | [[Category: Adiponectin]] | ||
| + | [[Category: Alternative splicing]] | ||
| + | [[Category: Chromosomal rearrangement]] | ||
| + | [[Category: Diabetes]] | ||
| + | [[Category: Diabetes mellitus]] | ||
| + | [[Category: Disease mutation]] | ||
| + | [[Category: Dna-binding]] | ||
| + | [[Category: Drug discovery]] | ||
| + | [[Category: Fragment-based drug discovery]] | ||
| + | [[Category: Metabolic disease]] | ||
| + | [[Category: Metal-binding]] | ||
| + | [[Category: Nucleus]] | ||
| + | [[Category: Obesity]] | ||
| + | [[Category: Phosphoprotein]] | ||
| + | [[Category: Polymorphism]] | ||
| + | [[Category: Ppar]] | ||
| + | [[Category: Pparg]] | ||
| + | [[Category: Ppargamma]] | ||
| + | [[Category: Proto-oncogene]] | ||
| + | [[Category: Receptor]] | ||
| + | [[Category: Scaffold-based drug discovery]] | ||
| + | [[Category: Transcription]] | ||
| + | [[Category: Transcription regulation]] | ||
| + | [[Category: Transferase]] | ||
| + | [[Category: Ubl conjugation]] | ||
| + | [[Category: Zinc]] | ||
| + | [[Category: Zinc-finger]] | ||
| + | |||
| + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Feb 18 09:06:13 2009'' | ||
Revision as of 07:06, 18 February 2009
Structure of PPARgamma with 3-[5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yl]-propionic acid
Template:ABSTRACT PUBMED 19116277
About this Structure
3ET3 is a 2 chains structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Artis DR, Lin JJ, Zhang C, Wang W, Mehra U, Perreault M, Erbe D, Krupka HI, England BP, Arnold J, Plotnikov AN, Marimuthu A, Nguyen H, Will S, Signaevsky M, Kral J, Cantwell J, Settachatgull C, Yan DS, Fong D, Oh A, Shi S, Womack P, Powell B, Habets G, West BL, Zhang KY, Milburn MV, Vlasuk GP, Hirth KP, Nolop K, Bollag G, Ibrahim PN, Tobin JF. Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent. Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):262-7. Epub 2008 Dec 30. PMID:19116277
Page seeded by OCA on Wed Feb 18 09:06:13 2009
Categories: Histone acetyltransferase | Homo sapiens | Wang, W. | Zhang, K Y.J. | Activator | Acyltransferase | Adiponectin | Alternative splicing | Chromosomal rearrangement | Diabetes | Diabetes mellitus | Disease mutation | Dna-binding | Drug discovery | Fragment-based drug discovery | Metabolic disease | Metal-binding | Nucleus | Obesity | Phosphoprotein | Polymorphism | Ppar | Pparg | Ppargamma | Proto-oncogene | Receptor | Scaffold-based drug discovery | Transcription | Transcription regulation | Transferase | Ubl conjugation | Zinc | Zinc-finger
